|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61K 47/64 | (2017.01) | ||
| A61K 47/60 | (2017.01) | ||
| A61K 47/59 | (2017.01) | ||
| A61K 38/22 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 3384925 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18169490.2 |
| Date of filing the European patent application | 2013-07-25 | |
| (97) | Date of publication of the European application | 2018-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 20120081475 | 2012-07-25 | KR |
| (72) |
Jung, Sung Youb, KR
Kim, Jin-Sun, KR
Jang, Myung Hyun, KR
Lee, Sang Hyun, KR
Choi, In Young, KR
Kwon, Se Chang, KR
|
| (73) |
Hanmi Pharm. Co., Ltd.,
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958,
KR
|
| (54) | COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE |
| COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE |